| 產(chǎn)品名稱 |
Human adenovirus 51 |
| 商品貨號 |
B208878 |
| Classification |
Adenoviridae, Mastadenovirus, Human adenovirus D |
| Agent |
Human adenovirus 51 |
| Strain |
Bom (RIVM no. 89-13959) |
| Applications |
Respiratory research |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
frozen |
| Storage Conditions |
-70°C or colder |
| Comments |
Hemagglutinates rat RBCs. |
| Effect on Host |
Cytopathic effects in culture include enlargement, rounding and clumping or roping of refractile cells. Cytopathic effects (CPE) in culture include enlargement, rounding and clumping or roping of refractile cells. |
| Growth Medium |
ATCC® Medium 30-2003: Eagle's Minimum Essential Medium (EMEM)
Fetal Bovine Serum
|
| Recommended Host |
Production Host: A549 (ATCC CCL-185) Recommended Host: A549 (ATCC CCL-185) Alternate Host(s): Human cell cultures, GaBi, HEp-2 |
| Name of Depositor |
JC de Jong
Ref de Jong JC, et al. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J. Clin. Microbiol. 37: 3940-3945, 1999. PubMed: 10565911 |
| Source |
Isolated from the fecal sample of a male AIDs patient suffering with diarrhea, Amsterdam, 1989. |
| References |
de Jong JC, et al. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J. Clin. Microbiol. 37: 3940-3945, 1999. PubMed: 10565911
de Jong JC, et al. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J. Clin. Microbiol. 37: 3940-3945, 1999. PubMed: 10565911
|